New Market Research Report: D-Pharm Ltd. - Product Pipeline Review - 2013

New Pharmaceuticals market report from Global Markets Direct: "D-Pharm Ltd. - Product Pipeline Review - 2013"


Boston, MA -- (SBWire) -- 08/20/2013 --Global Markets Direct's pharmaceuticals report, "D-Pharm Ltd. - Product Pipeline Review - 2013" provides data on the D-Pharm Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, D-Pharm Ltd.'s corporate website, SEC filings, investor presentations and featured press releases, both from D-Pharm Ltd. and industry-specific third party sources, put together by Global Markets Direct's team.


- D-Pharm Ltd. - Brief D-Pharm Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of D-Pharm Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of D-Pharm Ltd. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the D-Pharm Ltd.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate D-Pharm Ltd.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of D-Pharm Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the D-Pharm Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with D-Pharm Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of D-Pharm Ltd. and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Metastatic Pancreatic Cancer - Pipeline Review, H2 2013
- Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2013
- LG Life Sciences, Ltd. - Product Pipeline Review - 2013
- Shionogi & Co., Ltd. - Product Pipeline Review - 2013
- Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2013
- Inflammatory Pain - Pipeline Review, H1 2013
- Muscle Wasting Disorders - Pipeline Review, H1 2013
- Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2013
- Malignant Mesothelioma - Pipeline Review, H1 2013
- Kyowa Hakko Kirin Co., Ltd. - Product Pipeline Review - 2013

Media Relations Contact

Bill Thompson
Director of Marketing

View this press release online at: